Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,280Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Pharmathen SA

02 3APGDI

03 1Adalvo

04 2Ajanta Pharma Limited

05 3Alkem Laboratories

06 2Alter Laboratories Sa

07 2Apotex Inc

08 20Astellas Pharma

09 1Aurobindo Pharma Limited

10 1Avansor Pharma Oy

11 1CLONMEL HLTHCARE

12 1Cinfa

13 2Cipla Medpro South Africa

14 1GSK

15 1Glenmark Pharmaceuticals

16 2KMS Health Center

17 1LABORATORIOS NORMON SA

18 2Lupin Ltd

19 2MSN Laboratories

20 1Q Pharma Laboratories Sl

21 2Qilu Pharmaceutical

22 3STADA Arzneimittel

23 2Sawai Pharmaceutical Co

24 1Sunshine Lake Pharma

25 2Tecnimede

26 3Teva Pharmaceutical Industries

27 2Unichem Laboratories Limited

28 1Whanin Pharmaceutical

29 4Zentiva

30 2Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Mirabegron

Brand Name :

Dosage Form : Prolonged Release Tablet

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Mirabegron

Brand Name :

Dosage Form : Prolonged Release Tablet

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

03

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2025-09-24

Application Number : 218172

Regulatory Info : RX

Registration Country : USA

blank

04

Alkem Laboratories

SCOPE Summit
Not Confirmed
arrow

Alkem Laboratories

arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2024-02-12

Application Number : 215948

Regulatory Info : RX

Registration Country : USA

blank

05

Alkem Laboratories

SCOPE Summit
Not Confirmed
arrow

Alkem Laboratories

arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2024-02-12

Application Number : 215948

Regulatory Info : RX

Registration Country : USA

blank

06

APGDI

U.S.A
SCOPE Summit
Not Confirmed
arrow

APGDI

U.S.A
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2012-06-28

Application Number : 202611

Regulatory Info : RX

Registration Country : USA

blank

07

APGDI

U.S.A
SCOPE Summit
Not Confirmed
arrow

APGDI

U.S.A
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2012-06-28

Application Number : 202611

Regulatory Info : RX

Registration Country : USA

blank

08

APGDI

U.S.A
SCOPE Summit
Not Confirmed
arrow

APGDI

U.S.A
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ GRANULES

Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG/ML

Packaging :

Approval Date : 2021-03-25

Application Number : 213801

Regulatory Info : RX

Registration Country : USA

blank

09

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2025-01-02

Application Number : 209434

Regulatory Info : DISCN

Registration Country : USA

blank

10

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-01-02

Application Number : 209434

Regulatory Info : DISCN

Registration Country : USA

blank

11

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 209413

Regulatory Info :

Registration Country : USA

blank

12

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2022-09-28

Application Number : 209485

Regulatory Info : RX

Registration Country : USA

blank

13

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2022-09-28

Application Number : 209485

Regulatory Info : RX

Registration Country : USA

blank

14

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2025-06-30

Application Number : 217989

Regulatory Info : RX

Registration Country : USA

blank

15

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-06-30

Application Number : 217989

Regulatory Info : RX

Registration Country : USA

blank

16

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2019-12-27

Application Number : 209446

Regulatory Info : DISCN

Registration Country : USA

blank

17

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-05-06

Application Number : 217061

Regulatory Info : DISCN

Registration Country : USA

blank

18

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 216757

Regulatory Info :

Registration Country : USA

blank

19

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2022-09-29

Application Number : 209488

Regulatory Info : RX

Registration Country : USA

blank

20

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2022-09-29

Application Number : 209488

Regulatory Info : RX

Registration Country : USA

blank